Hyperfine Receives Frost & Sullivan Best Practices Product Innovation Award For World’s First Truly Portable MR Imaging Technology
Swoop™ Portable MRI system creates new product category for accessible, cost-effective MR imaging
Hyperfine’s Swoop™ Portable MRI has been recognized with a Best Practices Product Innovation Award for its category-defining point-of-care MR imaging technology.
Guilford, CT, Oct. 14, 2020 (GLOBE NEWSWIRE) — Hyperfine has received a Best Practices Product Innovation award from Frost & Sullivan for the company’s category-defining portable MR imaging technology. Analysts from Frost & Sullivan, a leading growth strategy and research firm, describe the disruptive innovation as a “massive leap forward to democratizing MRI.” Hyperfine’s Swoop™ Portable MRI System is a point-of-care MR imaging device that wheels directly to the patient’s bedside, plugs into a standard electrical wall outlet, and is controlled through a wireless tablet, making MR imaging accessible and immediate.
Magnetic Resonance Imaging (MRI) uses a magnetic field, radio waves, and a computer to produce detailed pictures of the body’s internal structures that are clearer, more detailed, and more likely in some instances to identify and accurately characterize disease than other imaging methods. However, fixed MRI systems can be inconvenient and inaccessible for providers and patients, particularly when time is critical such as with stroke. Transport to the MR suite demands complicated scheduling coordination, moving patients, and, often, 4- to 6-hour patient backlogs – all which compromise the utility of MRI as a diagnostic tool in time-sensitive settings such as intensive care units and emergency rooms. Furthermore, high capital investments, electrical power needs, and significant maintenance requirements present barriers to adoption across all populations, acutely so for developing countries and rural geographies.
Hyperfine designed the Swoop™ system to address the limitations of current imaging technologies and make MRI accessible anytime, anywhere, to any patient.